In Brief
This article was originally published in The Rose Sheet
Executive Summary
FDA says it continues to consider the Personal Care Products Council’s 2011 petition requesting guidance regarding safe levels of lead in cosmetic products; Hong Kong-based firm Li & Fung Limited acquires Lornamead for $190 million. More new in brief.
You may also be interested in...
Lornamead To Settle With FTC Over Deceptive Lice-Prevention Claims
Firm lacks scientific evidence for the claim that its Lice Shield shampoo and spray products reduce risk of lice infestation by more than 80%, among other statements made in advertisements and on product labeling. Under the terms of a proposed settlement, Lornamead will pay $500,000 to FTC and refrain from using unsupported claims or misrepresenting tests, studies or research in the context of product marketing.
FDA Cosmetics Update: 2013 AE Reports Tallied, 2014 Research Targeted
FDA says cosmetic-related adverse events were down in fiscal 2013, but suggests the decline may be due to a falloff in agency outreach and lower consumer awareness. The agency is focused on trace contaminants, with guidance in the works on lipstick lead, and aims to release its final guidance on cosmetic nanomaterials in the coming months, according to Linda Katz, director of FDA’s cosmetics office.
Unilever Looks To Personal-Care Innovation, Improved “Agility” In FY 2014
Unilever reports a 3% decline in FY 2013 turnover, but underlying sales growth was ahead of market, the firm says, crediting strong innovation in personal care and successes in emerging markets, among other factors. Going forward the firm aims to create efficiencies via SKU reductions and other streamlining efforts.